Telix’s development program will initially focus on the treatment of bladder cancer ... Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage ...
Investors interested in arranging a meeting with the Company’s management virtually during the conference should contact the Investor Summit conference coordinator. A live webcast of the presentation ...
The expanded portfolio access will help OpenText Distributors attract new, high-quality resellers and system integrators who have the right skills and work in the right markets to take full advantage ...
We issued our financial results press release before market and it is available at our website at www.twistbioscience.com ... Trends over the quarter and the year came from our Express product ...